There was a statistically significant difference in the number of CD8+ T cells and CD163+ M2 macrophages (p = .001 and p = .035, respectively) and in relation to tumor T stage (p = .011 and p = .009 respectively) between resectable and unresectable cases (Table 3). The gene discussed is CD8A; the disease is neoplasm.